ABCL
Price
$5.11
Change
+$0.09 (+1.79%)
Updated
Jul 25 closing price
Capitalization
1.53B
11 days until earnings call
NRSN
Price
$2.03
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
48.7M
31 days until earnings call
Interact to see
Advertisement

ABCL vs NRSN

Header iconABCL vs NRSN Comparison
Open Charts ABCL vs NRSNBanner chart's image
AbCellera Biologics
Price$5.11
Change+$0.09 (+1.79%)
Volume$5.19M
Capitalization1.53B
NeuroSense Therapeutics
Price$2.03
Change-$0.00 (-0.00%)
Volume$225.85K
Capitalization48.7M
ABCL vs NRSN Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. NRSN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and NRSN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ABCL: $5.11 vs. NRSN: $2.03)
Brand notoriety: ABCL and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 83% vs. NRSN: 66%
Market capitalization -- ABCL: $1.53B vs. NRSN: $48.7M
ABCL [@Biotechnology] is valued at $1.53B. NRSN’s [@Biotechnology] market capitalization is $48.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than NRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while NRSN’s TA Score has 2 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 4 bearish.
  • NRSN’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than NRSN.

Price Growth

ABCL (@Biotechnology) experienced а +14.32% price change this week, while NRSN (@Biotechnology) price change was -0.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 07, 2025.

NRSN is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.53B) has a higher market cap than NRSN($48.7M). ABCL YTD gains are higher at: 74.403 vs. NRSN (69.167). NRSN has higher annual earnings (EBITDA): -10.41M vs. ABCL (-211.2M). ABCL has more cash in the bank: 605M vs. NRSN (344K). NRSN has less debt than ABCL: NRSN (19K) vs ABCL (67.8M). ABCL has higher revenues than NRSN: ABCL (23.1M) vs NRSN (0).
ABCLNRSNABCL / NRSN
Capitalization1.53B48.7M3,131%
EBITDA-211.2M-10.41M2,028%
Gain YTD74.40369.167108%
P/E RatioN/AN/A-
Revenue23.1M0-
Total Cash605M344K175,872%
Total Debt67.8M19K356,842%
TECHNICAL ANALYSIS
Technical Analysis
ABCLNRSN
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 20 days ago
88%
Declines
ODDS (%)
Bearish Trend 28 days ago
86%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLYX2.380.01
+0.42%
flyExclusive
KO69.170.07
+0.10%
Coca-Cola Company
TMHC60.750.03
+0.05%
Taylor Morrison Home Corp
LILAK6.80-0.04
-0.58%
Liberty Latin America Ltd
TG9.07-0.07
-0.77%
Tredegar Corp

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+1.79%
CRSP - ABCL
59%
Loosely correlated
-1.97%
RXRX - ABCL
58%
Loosely correlated
+3.67%
ABSI - ABCL
54%
Loosely correlated
N/A
BEAM - ABCL
54%
Loosely correlated
+3.68%
NTLA - ABCL
53%
Loosely correlated
+6.38%
More

NRSN and

Correlation & Price change

A.I.dvisor tells us that NRSN and CTMX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRSN and CTMX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
N/A
CTMX - NRSN
31%
Poorly correlated
+0.42%
DNLI - NRSN
28%
Poorly correlated
-4.47%
VKTX - NRSN
27%
Poorly correlated
+2.75%
JANX - NRSN
25%
Poorly correlated
-0.04%
ABCL - NRSN
24%
Poorly correlated
+1.79%
More